It seems you have submitted a bad id and key to the form.

1. For GitHub ID, it needs to submit  as `carleshf`, not `github.com/carleshf`.

2. the SSH key needs the `ssh-rsa` header in front of the key. It was submitted 
without it.

Please resubmit.


Lori Shepherd

Bioconductor Core Team

Roswell Park Cancer Institute

Department of Biostatistics & Bioinformatics

Elm & Carlton Streets

Buffalo, New York 14263

________________________________
From: Turaga, Nitesh
Sent: Tuesday, October 24, 2017 9:34:15 AM
To: Shepherd, Lori
Cc: [email protected]
Subject: Fwd: EXTERNAL: Re: name of git repo for brgedata/BRGEdata package



Get Outlook for Android<https://aka.ms/ghei36>

________________________________
From: Carles Hern�ndez <[email protected]>
Sent: Tuesday, October 24, 2017 9:11:30 AM
To: Turaga, Nitesh
Cc: Juan Ram�n Gonzalez; Carlos Ruiz; Ramos Perez, Marcel; Morgan, Martin; Van 
Twisk, Daniel; Herv� Pag�s
Subject: EXTERNAL: Re: name of git repo for brgedata/BRGEdata package

Dear Nitesh,


I checked again if I can fetch the repo in order to push the properly changes 
to "brgedata" (and to "omicRexposome"). As you can see:

chernandez@workstation01 MINGW64 ~/Projects/BRGEdata (master)
$ git fetch --all
Fetching origin
Fetching upstream
Permission denied (publickey).
fatal: Could not read from remote repository.

Please make sure you have the correct access rights
and the repository exists.
error: Could not fetch upstream


Kind regards,

Carles Hernandez-Ferrer
Bioinformatic Analyst / PhD Student
ISGlobal
Barcelona Institute for Global Health - Campus Mar
Barcelona Biomedical Research Park (PRBB) (office 183.01 A)
Doctor Aiguader, 88
08003 Barcelona, Spain
Tel. +34 93 214 73 22
[email protected]<mailto:[email protected]>
www.isglobal.org<http://www.isglobal.org> | 
www.carleshf.com<http://www.carleshf.com>

We are pleased to tell you that after three years of a strategic alliance 
between ISGlobal and CREAL, both institutions have merged. The resulting 
institution, which retains the ISGlobal name, will build upon the existing 
areas of excellence to become a world-class player in research, education and 
innovation in Global Health. More info at http://ow.ly/krQd301Nj3w

On 21 October 2017 at 19:23, Herv� Pag�s 
<[email protected]<mailto:[email protected]>> wrote:
Thanks Carles for the update.

Please do "Reply All" on further communications. Thanks!

Regards,
H.


On 10/21/2017 12:50 AM, Carles Hern�ndez wrote:
Dear Herv�,


Yesterday I connacted Nitesh because it seems that I have some permision
problems with my user. We keep in mind that we msut solve this as fast
as possible.


Kidnr egards,

Carles Hernandez-Ferrer
Bioinformatic Analyst / PhD Student
*ISGlobal*
Barcelona Institute for Global Health - Campus Mar
Barcelona Biomedical Research Park (PRBB) (office 183.01 A)
Doctor Aiguader, 88
08003 Barcelona, Spain
Tel. +34 93 214 73 22<tel:%2B34%2093%20214%2073%2022>
[email protected]<mailto:[email protected]> 
<mailto:[email protected]<mailto:[email protected]>>
www.isglobal.org<http://www.isglobal.org>
<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.isglobal.org&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=KqEXQCfBzLuIGKqv-nudfrAMBK9vvNp9cwbDMpKrBOw&e=>
| www.carleshf.com<http://www.carleshf.com>
<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.carleshf.com&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=OfujD4doFtTBBAvjVFo0Ig9y4wpvkm1Gmbm2kzt4fZk&e=>
/
//We are pleased to tell you that after three years of a strategic
alliance between ISGlobal and CREAL, both institutions have merged. The
resulting institution, which retains the ISGlobal name, will build upon
the existing areas of excellence to become a world-class player in
research, education and innovation in Global Health. More info at
http://ow.ly/krQd301Nj3w
<https://urldefense.proofpoint.com/v2/url?u=http-3A__ow.ly_krQd301Nj3w&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=VyLQQzXOB1B-TsSyjAg7nJREJIPNSHILQW4-0-QIjWQ&e=>/

On 21 October 2017 at 09:02, Herv� Pag�s 
<[email protected]<mailto:[email protected]>
<mailto:[email protected]<mailto:[email protected]>>> wrote:

    Hi omicRexposome/BRGEdata developers,

    When the BRGEdata package was accepted, we added the brgedata git
    repo to the Bioconductor git server:

    https://git.bioconductor.org/packages/brgedata
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__git.bioconductor.org_packages_brgedata&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=HfuDh_Ddt-7u86QmKJK_vCohdqotR7-D8ei1GSOjKK0&e=>

    Unfortunately at the time we did this, the name of the git repo didn't
    match the name of the package (brgedata vs BRGEdata). This is causing
    problems in our build system and is preventing the package from showing
    up on the daily build report for data-experiment packages:

    https://bioconductor.org/checkResults/3.6/data-experiment-LATEST/
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__bioconductor.org_checkResults_3.6_data-2Dexperiment-2DLATEST_&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=GExsX_2mmkN7kjCHc9hDEcT1M3L9IuNn7bLxhD7ftnY&e=>

    This in turn is causing the omicRexposome package to fail on the daily
    builds:

    https://bioconductor.org/checkResults/3.6/bioc-LATEST/omicRexposome/
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__bioconductor.org_checkResults_3.6_bioc-2DLATEST_omicRexposome_&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=7rHy7hhpHAMZxl3d4GjOayfExvB3W_2S9kLfSE4D2Dg&e=>

    It seems that at some point you've renamed the package to brgedata on
    GitHub but it doesn't seem that this change was pushed to Bioconductor.

    Please keep in mind that now that your package is on the Bioconductor
    git server, your changes need to be pushed there too. See

    https://bioconductor.org/developers/how-to/git/
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__bioconductor.org_developers_how-2Dto_git_&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=XCUc9vWrZvqv1_g-0ox9Tzqf7hjadFiIKf93Jzx3InE&e=>

    for a collection of documents that cover all the aspects of maintaining
    a Bioconductor package via git/GitHub. In particular, see the
    "Push to GitHub and Bioconductor" document.

    Note that Marcel (cc'ed) reported this issue on GitHub a few days ago:

    https://github.com/isglobal-brge/brgedata/issues/1
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__github.com_isglobal-2Dbrge_brgedata_issues_1&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=qwAooENwuXnhBA_sSR-OkAjZ_Wl0vaJL5K8VJFm88fU&e=>

    Please let us know if you have questions or concerns about 
thi<https://maps.google.com/?q=r+concerns+about+thi&entry=gmail&source=g>s.

    Thanks for your contribution to Bioconductor.

    Regards,
    H.

    --
    Herv� Pag�s

    Program in Computational Biology
    Division of Public Health Sciences
    Fred Hutchinson Cancer Research Center
    1100 Fairview Ave. N
    
<https://urldefense.proofpoint.com/v2/url?u=https-3A__maps.google.com_-3Fq-3D1100-2BFairview-2BAve.-2BN-26entry-3Dgmail-26source-3Dg&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=D5LewGEiRujWbwC639yu6_2pOlp0miFTg1OGHbuKGp0&e=>,
    M1-B514
    P.O. Box 19024
    Seattle, WA 98109-1024

    E-mail: [email protected]<mailto:[email protected]> 
<mailto:[email protected]<mailto:[email protected]>>
    Phone: (206) 667-5791<tel:%28206%29%20667-5791> <tel:%28206%29%20667-5791>
    Fax: (206) 667-1319<tel:%28206%29%20667-1319> <tel:%28206%29%20667-1319>



This message is intended exclusively for its addressee and may contain
information that is CONFIDENTIAL and protected by professional
privilege. If you are not the intended recipient you are hereby notified
that any dissemination, copy or disclosure of this communication is
strictly prohibited by law. If this message has been received in error,
please immediately notify us via e-mail and delete it.

DATA PROTECTION. We inform you that your personal data, including your
e-mail address and data included in your email correspondence, are
included in the ISGlobal Foundation files. Your personal data will be
used for the purpose of contacting you and sending information on the
activities of the above foundations. You can exercise your rights of
access, rectification, cancellation and opposition by contacting the
following address: [email protected]<mailto:[email protected]> 
<mailto:[email protected]<mailto:[email protected]>>.
ISGlobal Privacy Policy at www.isglobal.org<http://www.isglobal.org>
<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.isglobal.org_&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=5D8HUtR8uPOtJ9CActvbav_89F6Kkjc7UfuilLnvqkA&e=>.

-----------------------------------------------------------------------------------------------------------------------------

CONFIDENCIALIDAD. Este mensaje y sus anexos se dirigen exclusivamente a
su destinatario y puede contener informaci�n confidencial, por lo que la
utilizaci�n, divulgaci�n y/o copia sin autorizaci�n est� prohibida por
la legislaci�n vigente. Si ha recibido este mensaje por error, le
rogamos lo comunique inmediatamente por esta misma v�a y proceda a su
destrucci�n.

PROTECCI�N DE DATOS. Sus datos de car�cter personal utilizados en este
env�o, incluida su direcci�n de e-mail, forman parte de ficheros de
titularidad de la Fundaci�n ISGlobal  para cualquier finalidades de
contacto, relaci�n institucional y/o env�o de informaci�n sobre sus
actividades. Los datos que usted nos pueda facilitar contestando este
correo quedar�n incorporados en los correspondientes ficheros,
autorizando el uso de su direcci�n de e-mail para las finalidades
citadas. Puede ejercer los derechos de acceso, rectificaci�n,
cancelaci�n y oposici�n dirigi�ndose 
[email protected]<mailto:[email protected]>
<mailto:[email protected]<mailto:[email protected]>>__. Pol�tica de privacidad 
enwww.isglobal.org<http://enwww.isglobal.org>
<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.isglobal.org_&d=DwMFaQ&c=eRAMFD45gAfqt84VtBcfhQ&r=BK7q3XeAvimeWdGbWY_wJYbW0WYiZvSXAJJKaaPhzWA&m=UE8YU4mmMrQG59VPEhHJQf3-VLQMLyzKZv9ZsmH74IA&s=5D8HUtR8uPOtJ9CActvbav_89F6Kkjc7UfuilLnvqkA&e=>.


--
Herv� Pag�s

Program in Computational Biology
Division of Public Health Sciences
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N, M1-B514
P.O. Box 19024
Seattle, WA 98109-1024

E-mail: [email protected]<mailto:[email protected]>
Phone:  (206) 667-5791<tel:%28206%29%20667-5791>
Fax:    (206) 667-1319<tel:%28206%29%20667-1319>



This message is intended exclusively for its addressee and may contain 
information that is CONFIDENTIAL and protected by professional privilege. If 
you are not the intended recipient you are hereby notified that any 
dissemination, copy or disclosure of this communication is strictly prohibited 
by law. If this message has been received in error, please immediately notify 
us via e-mail and delete it.

DATA PROTECTION. We inform you that your personal data, including your e-mail 
address and data included in your email correspondence, are included in the 
ISGlobal Foundation files. Your personal data will be used for the purpose of 
contacting you and sending information on the activities of the above 
foundations. You can exercise your rights of access, rectification, 
cancellation and opposition by contacting the following address: 
[email protected]<mailto:[email protected]>. ISGlobal Privacy Policy at 
www.isglobal.org<http://www.isglobal.org/>.

-----------------------------------------------------------------------------------------------------------------------------

CONFIDENCIALIDAD. Este mensaje y sus anexos se dirigen exclusivamente a su 
destinatario y puede contener informaci�n confidencial, por lo que la 
utilizaci�n, divulgaci�n y/o copia sin autorizaci�n est� prohibida por la 
legislaci�n vigente. Si ha recibido este mensaje por error, le rogamos lo 
comunique inmediatamente por esta misma v�a y proceda a su destrucci�n.

PROTECCI�N DE DATOS. Sus datos de car�cter personal utilizados en este env�o, 
incluida su direcci�n de e-mail, forman parte de ficheros de titularidad de la 
Fundaci�n ISGlobal  para cualquier finalidades de contacto, relaci�n 
institucional y/o env�o de informaci�n sobre sus actividades. Los datos que 
usted nos pueda facilitar contestando este correo quedar�n incorporados en los 
correspondientes ficheros, autorizando el uso de su direcci�n de e-mail para 
las finalidades citadas. Puede ejercer los derechos de acceso, rectificaci�n, 
cancelaci�n y oposici�n dirigi�ndose a 
[email protected]<mailto:[email protected]> . Pol�tica de privacidad en 
www.isglobal.org<http://www.isglobal.org/>.


This email message may contain legally privileged and/or confidential 
information.  If you are not the intended recipient(s), or the employee or 
agent responsible for the delivery of this message to the intended 
recipient(s), you are hereby notified that any disclosure, copying, 
distribution, or use of this email message is prohibited.  If you have received 
this message in error, please notify the sender immediately by e-mail and 
delete this email message from your computer. Thank you.
        [[alternative HTML version deleted]]

_______________________________________________
[email protected] mailing list
https://stat.ethz.ch/mailman/listinfo/bioc-devel

Reply via email to